Role and Mechanism of High Mobility Group Box 1 in Mediating Depression-Like Behaviors in Mice via Regulation of the 5-Hydroxytryptamine Receptor 7 Signaling Pathway
Abstract
Objective
To investigate the regulatory effects and underlying mechanisms of high mobility group box 1 (HMGB1) and 5-hydroxytryptamine receptor 7 (5-HT7R) on depressive-like behaviors in mice.
Methods
5-HT7R knockout (5-HT7R−/−) mice and their wild-type (WT) littermates were assigned to 4 groups, including the WT/control virus (AAV-Scramble), 5-HT7R−/−/AAV-Scramble, WT/HMGB1 overexpression virus (AAV-HMGB1), and 5-HT7R−/−/AAV-HMGB1 groups. Mice in the AAV-Scramble and AAV-HMGB1 groups received hippocampal injections of control virus and AAV-HMGB1, respectively. Three weeks later, the depression state of the mice were assessed with depressive behavior tests, the neuronal damage in the hippocampus was evaluated using immunofluorescence staining, and the ratio of reduced glutathione to oxidized glutathione (GSH/GSSG), the levels of Fe2+ and malondialdehyde (MDA), and superoxide dismutase (SOD) activity in the hippocampus were measured using commercial kits. Additionally, Western blot and ELISA were used to determine the levels of the 5-HT7R/cyclic adenosine monophosphate (cAMP)/protein kinase A (PKA) signaling pathway and the nuclear factor erythroid 2-related factor 2 (Nrf2)/cystine-glutamate exchanger (xCT)/glutathione peroxidase 4 (GPX4) signaling pathway in the hippocampus. Immunofluorescence double staining was performed to assess M2 microglial ferroptosis in the hippocampus. Finally, the mRNA levels of pro-inflammatory cytokines, interleukin (IL)-1β and tumor necrosis factor-α (TNF-α), and anti-inflammatory cytokines, IL-10 and arginase-1 (Arg-1), in the hippocampus was measuring using qRT-PCR.
Results
Compared with the AAV-Scramble group, hippocampal HMGB1 overexpression induced depressive-like behaviors and neuronal damage (P < 0.01), while 5-HT7R knockout alleviated these pathological phenotypes (P < 0.01). Compared with the AAV-Scramble group, HMGB1 overexpression reduced the GSH/GSSG ratio and SOD activity (both P < 0.01) and increased Fe2+ and MDA levels (both P < 0.01) in the hippocampus, whereas 5-HT7R knockout improved these ferroptosis-related indicators (P < 0.01). Compared with the AAV-Scramble group, HMGB1 overexpression upregulated 5-HT7R expression (P < 0.01) and downregulated the cAMP/PKA and Nrf2/xCT/GPX4 signaling pathways (P < 0.01) in the hippocampus, whereas 5-HT7R knockout ameliorated the reduction in these signaling pathways (P < 0.01). Compared with the AAV-Scramble group, HMGB1 overexpression upregulated the expression of 5-HT7R and ferritin heavy chain (FTH) in microglia (P < 0.01), downregulated Nrf2 expression (P < 0.01), and induced colocalization of FTH and CD206 (P < 0.01). 5-HT7R knockout reversed the changes in FTH and Nrf2 expression in microglia (P < 0.01) and reduced the colocalization of FTH and CD206 (P < 0.01). Furthermore, HMGB1 overexpression promoted the polarization of microglia to both the M1 and M2 types (P < 0.01) and upregulated the mRNA levels of pro-inflammatory (IL-1β and TNF-α) and anti-inflammatory (IL-10 and Arg-1) cytokines (P < 0.01), whereas 5-HT7R knockout attenuated microglial M1-type polarization and reduced the mRNA levels of the aforementioned pro-inflammatory cytokine (P < 0.01) while promoting microglial M2-type polarization and increasing the mRNA levels of the aforementioned anti-inflammatory cytokines (P < 0.01).
Conclusion
HMGB1 activates 5-HT7R and downregulates the cAMP/PKA/AKT/Nrf2/GPX4 signaling pathways, thereby mediating M2 microglial ferroptosis and neuroinflammation, ultimately promoting depressive-like behaviors in mice.
Keywords: High mobility group box 1, 5-Hydroxytryptamine receptor 7, Ferroptosis, Depression
Full Text:
PDFReferences
CHEN J, LIU J C, ZHANG P J, et al. Effects of vitamin B12 on behaviors, brain monoamine neurotransmitters, and brain-derived neurotrophic factor in depressive rats. J Sichuan Univ (Med Sci), 2025, 56(1): 206-214. doi: 10.12182/20250160608.
LONG Y, LI X Q, DENG J, et al. Modulating the polarization phenotype of microglia – A valuable strategy for central nervous system diseases. Ageing Res Rev, 2024, 93: 102160. doi: 10.1016/j.arr.2023.102160.
GUO B Q, ZHANG M Y, HAO W S, et al. Neuroinflammation mechanisms of neuromodulation therapies for anxiety and depression. Transl Psychiatry, 2023, 13(1): 5. doi: 10.1038/s41398-022-02297-y.
WANG H X, HE Y, SUN Z L, et al. Microglia in depression: an overview of microglia in the pathogenesis and treatment of depression. J Neuroinflammation, 2022, 19(1): 132. doi: 10.1186/s12974-022-02492-0.
WANG Y, LIU Z H, LI L Y, et al. Anti-ferroptosis exosomes engineered for targeting M2 microglia to improve neurological function in ischemic stroke. J Nanobiotechnology, 2024, 22(1): 291. doi: 10.1186/s12951-024-02560-y.
DU S Q, QIAN L F, XIONG L, et al. Ferroptosis: a new target for the treatment of depressive disorder. Chin Gen Prac, 2024, 27(12): 1417-1423. doi: 10.12114/j.issn.1007-9572.2023.0228.
MAO D, ZHENG Y, XU F F, et al. HMGB1 in nervous system diseases: a common biomarker and potential therapeutic target. Front Neurol, 2022, 13: 1029891. doi: 10.3389/fneur.2022.1029891.
DAVAANYAM D, LEE H, SEOL S I, et al. HMGB1 induces hepcidin upregulation in astrocytes and causes an acute iron surge and subsequent ferroptosis in the postischemic brain. Exp Mol Med, 2023, 55(11): 2402-2416. doi: 10.1038/s12276-023-01111-z.
LIU J, PANG S Y, ZHOU S Y, et al. , Lipocalin-2 aggravates blood-brain barrier dysfunction after intravenous thrombolysis by promoting endothelial cell ferroptosis via regulating the HMGB1/Nrf2/HO-1 pathway. Redox Biol, 2024, 76: 103342. doi: 10.1016/j.redox.2024.103342.
BIJATA M, BĄCZYŃSKA E, MÜLLER F E, et al. Activation of the 5-HT7 receptor and MMP-9 signaling module in the hippocampal CA1 region is necessary for the development of depressive-like behavior. Cell Rep, 2022, 38(11): 110532. doi: 10.1016/j.celrep.2022.110532.
BIJATA M, WIRTH A, WLODARCZYK J, et al. The interplay of serotonin 5-HT1A and 5-HT7 receptors in chronic stress. J Cell Sci, 2024, 137(19): jcs262219. doi: 10.1242/jcs.262219.
STROTH N, SVENNINGSSON P. S100B interacts with the serotonin 5-HT7 receptor to regulate a depressive -like behavior. Eur Neuropsychopharmacol, 2015, 25(12): 2372-2380. doi: 10.1016/j. euroneuro.2015.10.003.
WANG J. Research on the mechanism of 5-HT functional axis in mediating central vestibular compensation. Wuhan: Huazhong University of Science and Technology, 2024. doi:10.27157/d.cnki.ghzku.2024.000905.
SUN S M, SHEN J, JIANG J W, et al. Targeting ferroptosis opens new avenues for the development of novel therapeutics. Signal Transduct Target Ther, 2023, 8(1): 372. doi: 10.1038/s41392-023-01606-1.
HUANG X, WANG B, YANG J, et al. HMGB1 in depression: an overview of microglial HMBG1 in the pathogenesis of depression. Brain Behav Immun Health, 2023, 30: 100641. doi: 10.1016/j.bbih.2023.100641.
ZHOU H C, WANG X H, ZHANG B. Depression of lncRNA NEAT1 antagonizes LPS-evoked acute injury and inflammatory response in alveolar epithelial cells via HMGB1-RAGE signaling. Mediators Inflamm, 2020, 2020: 8019467. doi: 10.1155/2020/8019467.
XU K, WANG M Y, WANG H Y, et al. HMGB1/STAT3/p65 axis drives microglial activation and autophagy exert a crucial role in chronic Stress-Induced major depressive disorder. J Adv Res, 2024, 59: 79-96. doi: 10. 1016/j.jare.2023.06.003.
WU A B, ZHANG J Y. Neuroinflammation, memory, and depression: new approaches to hippocampal neurogenesis. J Neuroinflammation, 2023, 20(1): 283. doi: 10.1186/s12974-023-02964-x.
LI X M, TENG T, YAN W, et al. AKT and MAPK signaling pathways in hippocampus reveals the pathogenesis of depression in four stress-induced models. Transl Psychiatry, 2023, 13(1): 200. doi: 10.1038/s41398-023-02486-3.
RODNYY A Y, KONDAUROVA E M, BAZOVKINA D V, et al. Serotonin 5-HT7 receptor overexpression in the raphe nuclei area produces antidepressive effect and affects brain serotonin system in male mice. J Neurosci Res, 2022, 100(7): 1506-1523. doi: 10.1002/jnr.25055.
GOTTLIEB N, LI T Y, YOUNG A H, et al. The 5-HT7 receptor system as a treatment target for mood and anxiety disorders: A systematic review. J Psychopharmacol, 2023, 37(12): 1167-1181. doi: 10.1177/026988112 31211228.
CHEN W G, HE C Y, WEN B, et al. Biejiajian Pill regulates ferroptosis in hepatocellular carcinoma cells via p62/Keap1/NRF2 signaling pathway: a mechanism study. J Sichuan Univ (Med Sci), 2025, 56(1): 51-58. doi: 10. 12182/20250160502.
Refbacks
- There are currently no refbacks.



